67 related articles for article (PubMed ID: 2728496)
1. Molecular orbital calculations on tumour-inhibitory aniline mustards: QSARs.
Lewis DF
Xenobiotica; 1989 Feb; 19(2):243-51. PubMed ID: 2728496
[TBL] [Abstract][Full Text] [Related]
2. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
[TBL] [Abstract][Full Text] [Related]
4. Potential anticancer agents. XX. 2. Quantitative structure--activity relationships (QSAR) in aromatic nitrogen mustards area.
Niculescu-Duvăz I; Stihi G; Crăescu T; Simon Z
Neoplasma; 1980; 27(3):271-8. PubMed ID: 7453847
[TBL] [Abstract][Full Text] [Related]
5. Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards.
Turner PR; Denny WA; Ferguson LR
Anticancer Drug Des; 2000 Aug; 15(4):245-53. PubMed ID: 11200500
[TBL] [Abstract][Full Text] [Related]
6. DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the reactivity of the mustard.
Gourdie TA; Valu KK; Gravatt GL; Boritzki TJ; Baguley BC; Wakelin LP; Wilson WR; Woodgate PD; Denny WA
J Med Chem; 1990 Apr; 33(4):1177-86. PubMed ID: 2319563
[TBL] [Abstract][Full Text] [Related]
7. The cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl)amino] benzoic acid.
Sunters A; Springer CJ; Bagshawe KD; Souhami RL; Hartley JA
Biochem Pharmacol; 1992 Jul; 44(1):59-64. PubMed ID: 1632839
[TBL] [Abstract][Full Text] [Related]
8. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
[TBL] [Abstract][Full Text] [Related]
9. Bacterial mutagenicity studies of DNA-intercalating aniline mustards: an insight into the mode of action of a novel class of anti-tumour drugs.
Ferguson LR; Gourdie TA; Valu KK; Denny WA
Anticancer Drug Des; 1989 Oct; 4(3):209-19. PubMed ID: 2679621
[TBL] [Abstract][Full Text] [Related]
10. Reactions of nitrogen mustards with DNA.
Hemminki K; Kallama S
IARC Sci Publ; 1986; (78):55-70. PubMed ID: 3583398
[TBL] [Abstract][Full Text] [Related]
11. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards.
Mattes WB; Hartley JA; Kohn KW
Nucleic Acids Res; 1986 Apr; 14(7):2971-87. PubMed ID: 3960738
[TBL] [Abstract][Full Text] [Related]
12. The 5'-GNC preference for mustard cross-linking is preserved in a restriction fragment.
Millard JT; Luedtke NW; Spencer RJ
Anticancer Drug Des; 1996 Sep; 11(6):485-92. PubMed ID: 8836112
[No Abstract] [Full Text] [Related]
13. DNA-directed alkylating ligands as potential antitumor agents: sequence specificity of alkylation by intercalating aniline mustards.
Prakash AS; Denny WA; Gourdie TA; Valu KK; Woodgate PD; Wakelin LP
Biochemistry; 1990 Oct; 29(42):9799-807. PubMed ID: 2271617
[TBL] [Abstract][Full Text] [Related]
14. Polybenzamide mustards: structure-activity relationships for DNA sequence-specific alkylation.
Turner PR; Ferguson LR; Denny WA
Anticancer Drug Des; 1999 Feb; 14(1):61-70. PubMed ID: 10363028
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
[TBL] [Abstract][Full Text] [Related]
16. Bifunctional constructs of aspirin and ibuprofen (non-steroidal anti-inflammatory drugs; NSAIDs) that express antibacterial and alkylation activities.
Bartzatt R; Cirillo SL; Cirillo JD; Donigan L
Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):273-82. PubMed ID: 12533193
[TBL] [Abstract][Full Text] [Related]
17. Potential anticancer agents. XVII. New developments in the benzoic acid nitrogen mustards area.
Niculescu-Duvăz I; Feyns V; Dobre V
Cancer Treat Rep; 1978 Dec; 62(12):2045-54. PubMed ID: 751714
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship of aniline mustards acting against B-16 melanoma in mice.
Panthananickal A; Hansch C; Leo A
J Med Chem; 1979 Oct; 22(10):1267-9. PubMed ID: 513075
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents.
Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912
[TBL] [Abstract][Full Text] [Related]
20. DNA minor groove targeted alkylating agents based on bisbenzimidazole carriers: synthesis, cytotoxicity and sequence-specificity of DNA alkylation.
Smaill JB; Fan JY; Denny WA
Anticancer Drug Des; 1998 Dec; 13(8):857-80. PubMed ID: 10335264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
